524518 logo

Krebs Biochemicals & Industries Limited Stock Price

BSE:524518 Community·₹1.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

524518 Share Price Performance

₹0
-79.21 (-100.00%)
₹0
-79.21 (-100.00%)
Price ₹0

524518 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
1 Reward

Krebs Biochemicals & Industries Limited Key Details

₹230.2m

Revenue

₹53.3m

Cost of Revenue

₹176.9m

Gross Profit

₹405.5m

Other Expenses

-₹228.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-10.60
76.83%
-99.30%
-137.7%
View Full Analysis

About 524518

Founded
1991
Employees
202
CEO
Manish Jain
WebsiteView website
krebsbiochem.com

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.

Recent 524518 News & Updates

Recent updates

No updates